Strategic Divisional MIS & Accounts Lead

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to its customers across geographies. We organise our business into two segments, namely, Specialty Pharmaceuticals, comprising Radiopharmaceuticals (including Radio pharmacies), Contract Manufacturing of Sterile Injectable, Non-sterile & Allergy Therapy Products, and Generics Solid Dosage Formulations.

Jubilant Generics (JGL) is a wholly - owned subsidiary of Jubilant Pharma which is subsidiary to Jubilant Pharmova Limited. Jubilant Generics have 2 manufacturing sitedat Roorkee, Uttarakhand and Salisbury, Maryland, USAengaged in manufacturing of Tablets and Capsules. The manufacturing location at Roorkee, Uttarakhand is state of the art facility and is audited and approved by USFDA, Japan PMDA, UK MHRA, TGA, WHO and Brazil ANVISA.

This business team focusses on B2B model for EU, Canada and emerging markets.

All compliance related filing and support towards ROC and tax team. And other business support

• Ensuring timely compliance of all ROC, Direct and Indirect Taxes related to filing and support to respective team.
• Also support to business on the case-to-case requirements.

Budget and Strategy preparation. Console Monthly Cash Flow, WC, NOD & Projections (JGL,IBP, Subsidiary).

• Preparation and controlling of budget and strategy for Corporate and R&D.
• Monitoring the variance in actual vis-a-vis approved budget.
• Preparation of MIS for JGL and other foreign entities.
• Forecasting of cash flow and working capital.

Corporate and R&D related expenses and cross charge.

• Monitoring of Corporate and R&D expenses and ensuring the expenses are done through purchase order.
• Analysis of actual expenses in comparison to approved budget and are with-in budget.

FS and Audit of JGL (Legal entity). Audit support and Quarterly and Annual results in HFM. FAR, Capex and controlling. IAUD, R&D.

• Financials statements as per IndAS-1 for all legal entities and coordinating with statutory auditors.
• HFM and other related activities.
• Controlling of Capex and product development expenses, capitalisation of IUD, Compliance with IndAS 116.

Intercompany transactions and RPT disclosure.

• Ensure all inter-company agreements should be in place for each transactions executed and transaction done in accordance of omnibus approval granted.
• Preparation of RPT schedule and information for secretarial team.

Monthly TB closure including ECL and other quarterly or annual provisions. Any new requirement (Ad-Hoc).

• Monthly review of TB and ensuring all requisite provision for has been account for.
• Computation and providing ECL provision in books of accounts after getting approved from management.
• Impairment testing in accordance with IndAS 36.